Ignite Creation Date:
2025-12-25 @ 1:44 AM
Ignite Modification Date:
2025-12-26 @ 12:01 AM
Study NCT ID:
NCT05741294
Status:
COMPLETED
Last Update Posted:
2025-02-20
First Post:
2023-02-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses
Sponsor:
Almirall, S.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-20
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-19
Completion Date Type:
ACTUAL
First Submit Date:
2023-02-14
First Submit QC Date:
None
Study First Post Date:
2023-02-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-01-13
Results First Submit QC Date:
None
Results First Post Date:
2025-02-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-19
Last Update Post Date:
2025-02-20
Last Update Post Date Type:
ACTUAL